1Robinson M.New-generation proton pump inhibitors:overcoming the limitations of early-generation agents[J].Eur J Gastroenterol Hepatol,2001,13(Suppl1):S43.
2Hassa-Alin M,Andersson T,Brelberg E,et al.Pharmacokinetic study of esomeprazole of the oral and intravenous administration of single and repeated doses to healthy subjects[J].Eur J Clin Pharmacol,2000,56 (9-10):665.
3Lind T,Pydlerg L,Kyleback A,et al.Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-esophageal reflux disease[J].Aliment pharmacol,2000,14(7):861.
6Miner P JR,Katz PO,Chen Y,et al.Gastric acid control with esomeprazole,lansoprazole,omeprazole,pantoprazole and rabeprazole:a five-way crossover study[J].Am J Gastroenterol,2003,98(12):2616.
7Edwards SJ,Lind T,Lundell L.Systematic review of proton pump inhibitors for the acute treatment of reflux exophagitis[J].Aliment pharmacol ther,2001,15(11):1729.
8Richter JE,Kahrilas PG,Johanson J,et al.Efficacy and safety of esomeprazole compared with omeprazole in GERD patient with erosive esophagitis:A randomized controlled trial[J].Am J Gastroenterol,2001,96(3):656.
9Johnson DA,Benjamin SB,Vakil NB,et al.Esomeprazole once daily for 6 months.Is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms:A randomized double-blind,placobo-controlled study of efficacy and safety[J].Am J Gastroenterol,2001,96(1):27.
10Fennerty MB,Johanson JF,Hwang C,et al.Efficacy of esomeprazole 40mg vs Lansoprazole 30 mg for healing moderate to severe erosive oesophagitis[J].Aliment pharmacol ther,2005,21(4):455.
二级参考文献13
1Sachs G，Aliment Pharmacol Ther，2000年，14卷，1383页
2Li Y，J Gastroenterol Hepatol，2000年，15卷，148页
3Wilder-Smith C, Rohss K, Claar-Nilsson C, et al. Esomeprazole 40 mg provides more effective acid control than rabeprazole 20 mg.Gut, 2000, 47(suppl 3) :A63.
4Horai Y, Kimura M, Furuie H, et al. Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP 2C19 genotypes. Aliment Pharmacol Ther, 2001, 15:793-803.
5Castell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole (40 mg)compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol, 2002, 97:575-583.
6Kahrilas PJ, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Aliment Pharmacol Ther, 2000, 14:1249-1258.
7Edwards SJ, Lind T, Lundell L. Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis. Aliment Pharmacol Ther, 2001, 15:1729-1736.
8Talley NJ, Lauritsen K, Tunturi-Hihnala H, et al. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of ''on-demand'' therapy for 6 months. Aliment Pharmacol Ther, 2001, 15:347-354.
9Lind T, Rydberg L, Kyleback A, et al. Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther, 2000,14: 861-867.
10Tsuneoka T, Fukushima K, Matsuo Y, et al. Genotype analysis of the CYP 2C19 gene in the Japanese population. Life Sci, 1996,59:1711-1715.
